Wan Bond: Announcement on the establishment of a wholly-owned subsidiary
Wan Bond: Notice on Wholly-owned Subsidiary Drugs Obtaining Conformity Evaluation Registration Approval
Wan Bond: Announcement on the Resignation of Director and Chief Financial Officer
Wan Bond: Summary table of non-operating capital usage and other related capital transactions for the first half year
Wan Bond: 2024 semi-annual financial report
Wanbangde Pharmaceutical Holding Group: Announcement on the signing of the "Compensation Agreement for the Acquisition of Houses on State-owned Land" by the subsidiary.
Wanbangde Pharmaceutical Holding Group: Announcement on the subsidiary's products being certified as orphan drugs by the US FDA
Wanbangde Pharmaceutical Holding Group: Wan Bond's 2023 Annual General Meeting of Shareholders Legal Opinion
Wanbangde Pharmaceutical Holding Group: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Wanbangde Pharmaceutical Holding Group: Notice on convening the 2023 Annual General Meeting of Shareholders (after correction)
Wanbangde Pharmaceutical Holding Group: Corrective Notice Concerning the Notice of Convening the 2023 Annual General Meeting of Shareholders
Wanbangde Pharmaceutical Holding Group: Notice on subsidiary products receiving US FDA drug certification for rare pediatric diseases
Wanbangde Pharmaceutical Holding Group: Notice of Annual General Meeting of Shareholders
Wanbangde Pharmaceutical Holding Group: Internal Control Self-Assessment Report
Wanbangde Pharmaceutical Holding Group: Remuneration and Committee Rules of Procedure (2024.4)
Wanbangde Pharmaceutical Holding Group: Shareholder return plan for the next three years (2024-2026)
Wanbangde Pharmaceutical Holding Group: Announcement on preparing to accrue asset impairment
Wanbangde Pharmaceutical Holding Group: 2023 Financial Results Report
Wan Bond: Announcement on the wholly-owned subsidiary passing the Korean MFDS on-site inspection
Wan Bond: Announcement on cooperative investment between wholly-owned subsidiaries and professional investment institutions
No Data